Alistair Boath has been working as the Compound Strategy Development Director at Beckley Psytech since October 2022. Prior to that, they held the role of Digital Integration and Access Director at the same company from October 2021 to October 2022. Before joining Beckley Psytech, Alistair was the Commercial Director for UK and Ireland at Otsuka Pharmaceuticals from January 2020 to October 2021. Alistair also worked at Otsuka Pharmaceutical Companies Europe, where they held various roles including Commercial Director for CNS from January 2019 to December 2019, Market Access Director for Neurology from April 2017 to December 2018, Market Access Lead from March 2015 to April 2017, and Market Access Manager (Contractor) from September 2014 to March 2015. Alistair has experience as a Freelance Market Access Consultant and worked independently from September 2014 to March 2015. Alistair'searlier experience includes working as a Management Consultant at WG Consulting from January 2012 to August 2014, and as a Research Associate at WG Consulting from July 2008 to June 2010.
Alistair Boath attended The University of Manchester from 2004 to 2008, where they received a 1st degree in Pharmacology with Industrial Experience.
April 1, 2024 - present
October, 2022
October, 2021